(Q37624379)

English

Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors

scientific article published on 27 August 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors (English)

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

0 references

author name string

Minati Satpathy

1

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Liya Wang

2

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Rafal Zielinski

3

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Weiping Qian

4

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Malgorzata Lipowska

5

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Jacek Capala

6

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Gee Young Lee

7

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Hong Xu

8

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Y Andrew Wang

9

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Hui Mao

10

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Lily Yang

11

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

publication date

27 August 2013

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

544-555

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Affibody-DyLight conjugates for in vivo assessment of HER2 expression by near-infrared optical imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Rethinking ovarian cancer: recommendations for improving outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

T₁-weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Delivering nanomedicine to solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Near IR heptamethine cyanine dye-mediated cancer imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Imaging ovarian cancer and peritoneal metastases--current and emerging techniques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

PET/NIRF/MRI triple functional iron oxide nanoparticles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Near-infrared fluorescence: application to in vivo molecular imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Receptor-targeted nanoparticles for in vivo imaging of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

The biology of ovarian cancer: new opportunities for translation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

HER2 status in ovarian carcinomas: a multicenter GINECO study of 320 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Nanoparticle imaging of integrins on tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Ovarian cancer metastasis: integrating insights from disparate model organisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Cancer of the ovary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

HER2 expression in cervical cancer as a potential therapeutic target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Ovarian cancer: strategies for overcoming resistance to chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Shedding light onto live molecular targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Ovarian cancer: progress and continuing controversies in management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

Hepatic tumor imaging using iron oxide MRI: comparison with computed tomography, clinical impact, and cost analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

23 August 2017

In vivo NIRF and MR dual-modality imaging using glycol chitosan nanoparticles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

6 September 2017

Potential of PET to predict the response to trastuzumab treatment in an ErbB2-positive human xenograft tumor model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

6 September 2017

Continuous docetaxel chemotherapy improves therapeutic efficacy in murine models of ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

14 September 2017

Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

14 September 2017

MR molecular imaging of HER-2 in a murine tumor xenograft by SPIO labeling of anti-HER-2 affibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

14 September 2017

Mediating tumor targeting efficiency of nanoparticles through design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

14 September 2017

On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

14 September 2017

Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

14 September 2017

A dual fluorochrome probe for imaging proteases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

14 September 2017

Pulmonary metastases in ovarian cancer. Analysis of 357 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

14 September 2017

p185neu expression in human lung adenocarcinomas predicts shortened survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

25 June 2018

Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

1 September 2018

Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

1 September 2018

In vivo imaging of tumor response to therapy using a dual-modality imaging strategy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

1 September 2018

EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

1 September 2018

A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

1 September 2018

Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946402

2 October 2018

Does a targeting ligand influence nanoparticle tumor localization or uptake?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu: a differentiation marker in adenocarcinoma of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary surgical cytoreduction for advanced ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis of monodisperse iron oxide nanocrystals by thermal decomposition of iron carboxylate salts

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of the oncogene c-erbB-2 (HER2/neu) and response to chemotherapy in patients with ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/SMLL.201301593

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

release_bqois7tokfbl3ikl4vrf4xhmm4

1 reference

https://api.fatcat.wiki/v0/release/bqois7tokfbl3ikl4vrf4xhmm4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37624379&oldid=2150111626"